Mobile

A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s dis...

Update Il y a 4 ans
Reference: EUCTR2004-004854-19

A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To identify one or more effective doses of ITF 2357 in the management of Crohn’s disease suitable for further evaluation in phase III studies

Inclusion criteria

  • Crohn’s Disease

Links